Hemorrhagic fever viruses

Pigott, David C.

doi:10.1016/j.ccc.2005.06.007

Cited by 61Viral Infections and VectorsViral Infections and Outbreaks ResearchBacillus and Francisella bacterial research

Hemorrhagic fever viruses

Open access

Pigott, David C.·2005·Critical Care Clinics

DOI 10.1016/j.ccc.2005.06.007PMC PMC7119092

Open this paper in CoChat — free account Open PDF

Abstract

The previously unthinkable prospect of bioterrorism has become, in the post September 11 political climate, a proven threat that presents a substantial, ongoing risk to industrialized nations. This risk requires a healthy respect for the capabilities of the most lethal potential agents of bioterrorism, in this case, the viral hemorrhagic fevers. These lethal viruses represent a continuing public health threat in endemic areas. Now, because of the ease and speed of global travel, business travelers and tourists unwittingly infected with these deadly pathogens are arriving without warning at hospitals in industrialized nations, presenting novel diagnostic challenges—as well as significant new risks—to western health care workers and hospital employees. By recognizing risk factors for both naturally acquired VHF infection as well as signs and symptoms of a VHF-based bioterrorism attack, physicians and other health care workers who use proper barrier precautions can evaluate and manage patients suspected of harboring VHF infection and at the same time minimize the infectious risk of these highly contagious and potentially lethal pathogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccc.2005.06.007

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

During viral infection, high levels of •NO can produce undesirable effects in the patient, such as hemorrhagic fever.
“In contrast, during viral infection, high levels of •NO can produce some undesirable effects in the patient, such as hemorrhagic fever [136].”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [136]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Lassa Fever
McCormick, J. B., King, I. J., Webb, P. A., Scribner, C. L., Craven, R. B., Johnson, K. M., Elliott, L. H., & Belmont-Williams, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601023140104 · Cited by 994 · see citing works
Hemorrhagic Fever Viruses as Biological Weapons
Borio, L. L., Inglesby, T. V., Peters, C. J., Schmaljohn, A. L., Hughes, J. M., Jahrling, P. B., Ksiazek, T. G., Johnson, K. M., Meyerhoff, A., O’Toole, T., et al. (2002) · JAMA · doi:10.1001/jama.287.18.2391 · Cited by 672 · see citing works
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655 · see citing works
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 577 · see citing works
Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome
Towner, J. S., Rollin, P. E., Bausch, D. G., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4330-4341.2004 · Cited by 517 · see citing works
Ebola Hemorrhagic Fever in Kikwit, Democratic Republic of the Congo: Clinical Observations in 103 Patients
Bwaka, M. A., Bonnet, M., Calain, P., Colebunders, R., Roo, A. D., Guimard, Y., Katwiki, K. R., Kibadi, K., Kipasa, M., Kuvula, K., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514308 · Cited by 466 · see citing works
The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995
Khan, A. S., Tshioko, F. K., Heymann, D. L., Guenno, B. L., Nabeth, P., Kerstiëns, B., Fleerackers, Y., Kilmarx, P. H., Rodier, G. R., Nkuku, O. B., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514306 · Cited by 460 · see citing works
Lassa fever: epidemiology, clinical features, and social consequences
Richmond, J. K., & Baglole, D. J. (2003) · BMJ · doi:10.1136/bmj.327.7426.1271 · Cited by 459 · see citing works
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
Mupapa, K., Massamba, M., Kibadi, K., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514298 · Cited by 421 · see citing works
A Case-Control Study of the Clinical Diagnosis and Course of Lassa Fever
McCormick, J. B., King, I. J., Webb, P. A., et al. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.3.445 · Cited by 411 · see citing works
Clinical, Virologic, and Immunologic Follow‐Up of Convalescent Ebola Hemorrhagic Fever Patients and Their Household Contacts, Kikwit, Democratic Republic of the Congo
Rowe, A. K., Bertolli, J., Khan, A. S., Mukunu, R., Muyembe‐Tamfum, J. J., Bressler, D. S., Williams, A. J., Peters, C. J., Rodrı́guez, L. L., Feldmann, H., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514318 · Cited by 385 · see citing works
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys
Geisbert, T. W., Hensley, L. E., Jahrling, P. B., Larsen, T., Geisbert, J. B., Paragas, J., Young, H. A., Fredeking, T., Rote, W. E., & Vlasuk, G. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15012-x · Cited by 375 · see citing works
Biohazard: the chilling true story of the largest covert biological weapons program in the world--told from the inside by the man who ran it
(1999) · Choice Reviews Online · doi:10.5860/choice.37-0912 · Cited by 348 · see citing works
Biological and Chemical Terrorism: Strategic Plan for Preparedness and Response: Recommendations of the CDC Strategic Planning Workgroup
(2000) · PsycEXTRA Dataset · doi:10.1037/e548092006-001 · Cited by 325 · see citing works
Wild Animal Mortality Monitoring and Human Ebola Outbreaks, Gabon and Republic of Congo, 2001–2003
Rouquet, P., Froment, J.-M., Bermejo, M., Kilbourn, A. M., Karesh, W. B., Reed, P. E., Kumulungui, B., Yaba, P., Delicat, A., Rollin, P. E., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1102.040533 · Cited by 323 · see citing works
Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
Geisbert, T. W., Young, H. A., Jahrling, P. B., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63592-4 · Cited by 318 · see citing works
Markedly Elevated Levels of Interferon (IFN)‐σ, IFN‐α, Interleukin (IL)‐2, IL‐10, and Tumor Necrosis Factor‐α Associated with Fatal Ebola Virus Infection
Villinger, F. J., Rollin, P. E., Brar, S. S., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 309 · see citing works
The Tokyo Subway Sarin Attack: Disaster Management, Part 1: Community Emergency Response*
Okumura, T., Suzuki, K., Fukuda, A., Kohama, A., Takasu, N., Ishimatsu, S., & Hinohara, S. (1998) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.1998.tb02470.x · Cited by 286 · see citing works
Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.
Johnson, E. D., Jaax, N., White, J., et al. (1995) · PubMed · Cited by 269 · see citing works
An Introduction to Ebola: The Virus and the Disease
Peters, C., & LeDuc, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514322 · Cited by 261 · see citing works
Protective Efficacy of a Live Attenuated Vaccine against Argentine Hemorrhagic Fever
Maiztegui, J. I., McKee, K. T., Oro, J. G. B., Harrison, L. H., Gibbs, P., Feuillade, M. R., Enria, D. A., Briggiler, A. M., Levis, S., Ambrosio, A. M., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514211 · Cited by 261 · see citing works
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
Feldmann, H., Bugany, H., Mahner, F., Klenk, H. D., Drenckhahn, D., & Schnittler, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2208-2214.1996 · Cited by 255 · see citing works
Ebola virus-like particles protect from lethal Ebola virus infection
Warfield, K. L., Bosio, C. M., Welcher, B. C., Deal, E. M., Mohamadzadeh, M., Schmaljohn, A. L., Aman, M. J., & Bavari, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237038100 · Cited by 246 · see citing works
A Novel Immunohistochemical Assay for the Detection of Ebola Virus in Skin: Implications for Diagnosis, Spread, and Surveillance of Ebola Hemorrhagic Fever
Zaki, S. R., Shieh, W., Greer, P. W., Goldsmith, C. S., Ferebee, T., Katshitshi, J., Tshioko, F. K., Bwaka, M. A., Swanepoel, R., Calain, P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514319 · Cited by 235 · see citing works
- Hemorrhagic Fever with Renal Syndrome
Singh, S. K., & Ruzek, D. (2013) · CRC Press eBooks · doi:10.1201/b15172-28 · Cited by 233 · see citing works
[The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note].
Brès, P. (1978) · PubMed · Cited by 228 · see citing works
Arenaviruses other than Lassa virus
Charrel, R. N., & de Lamballerie, X. N. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00202-4 · Cited by 215 · see citing works
Imported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & SCHMITZ, H. E. (2000) · Emerging infectious diseases · doi:10.3201/eid0605.000504 · Cited by 197 · see citing works
Lassa fever Epidemiological aspects of the 1970 epidemic, Jos, Nigeria
Carey, D. E., Kemp, G. E., White, H. A., et al. (1972) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(72)90271-4 · Cited by 184 · see citing works
IMPORTANCE OF DOSE OF NEUTRALISING ANTIBODIES IN TREATMENT OF ARGENTINE HAEMORRHAGIC FEVER WITH IMMUNE PLASMA
Enria, D. A., Fernandez, N., Briggiler, A., Levis, S., & Maiztegui, J. I. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90299-x · Cited by 183 · see citing works
Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000–January 2001)
Lamunu, M., Lutwama, J. J., Kamugisha, J., Opio, A. A., Nambooze, J., Ndayimirije, N., & Okware, S. I. (2003) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.04.001 · Cited by 173 · see citing works
Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation
Bausch, D. G., Rollin, P. E., Demby, A. H., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.7.2670-2677.2000 · Cited by 170 · see citing works
Effect of environmental factors on aerosol‐induced lassa virus infection
Stephenson, Ε. H., Larson, E. W., & Dominik, J. W. (1984) · Journal of Medical Virology · doi:10.1002/jmv.1890140402 · Cited by 167 · see citing works
Imported Lassa Fever in Germany: Surveillance and Management of Contact Persons
Haas, W., Breuer, T., Pfaff, G., SCHMITZ, H. E., Kohler, P., Asper, M., Emmerich, P., Drosten, C., Gölnitz, U., Fleischer, K., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374853 · Cited by 165 · see citing works
Viral Hemorrhagic Fevers
Marty, A. M., Jahrling, P. B., & Geisbert, T. W. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.05.001 · Cited by 162 · see citing works
Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory
Jaax, N. K., Jahrling, P. B., Geisbert, T. W., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92841-3 · Cited by 161 · see citing works
Antiviral treatment of argentine hemorrhagic fever
Enria, D. A., & Maiztegui, J. I. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90030-2 · Cited by 161 · see citing works
Molecular diagnostics of viral hemorrhagic fevers
Drosten, C., Kümmerer, B. M., SCHMITZ, H. E., et al. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00201-2 · Cited by 159 · see citing works
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions
Geisbert, T. W., & Hensley, L. E. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404008300 · Cited by 142 · see citing works
Role of the endothelium in viral hemorrhagic fevers
Peters, C. J., & Zaki, S. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00016 · Cited by 135 · see citing works
Outbreak of Ebola Hemorrhagic Fever—Uganda, August 2000-January 2001
(2001) · JAMA · doi:10.1001/jama.285.8.1010-jwr0228-2-1 · Cited by 130 · see citing works
Treatment of a Laboratory-Acquired Sabiá Virus Infection
Barry, M., Russi, M. B., Armstrong, L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330505 · Cited by 121 · see citing works
Defense against filoviruses used as biological weapons
Bray, M. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00200-0 · Cited by 116 · see citing works
Hemorrhagic Fever with Renal Syndrome in Korea
Lee, H. W. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_4.s864 · Cited by 114 · see citing works
Rapid detection protocol for filoviruses
Weidmann, M., Mühlberger, E., & Hufert, F. T. (2003) · Journal of Clinical Virology · doi:10.1016/j.jcv.2003.09.004 · Cited by 106 · see citing works
Nuclear Blindness: An Overview of the Biological Weapons Programs of the Former Soviet Union and Iraq
Davis, C. J. (1999) · Emerging infectious diseases · doi:10.3201/eid0504.990408 · Cited by 105 · see citing works
Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects
Richards, G. A., Murphy, S., Jobson, R., Mer, M., Zinman, C., Taylor, R., Swanepoel, R., Duse, A., Sharp, G., Rey, I. C. J. D. L., et al. (2000) · Critical Care Medicine · doi:10.1097/00003246-200001000-00041 · Cited by 102 · see citing works
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
Warfield, K. L., Swenson, D. L., Negley, D. L., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.063 · Cited by 97 · see citing works
Potential Mammalian Filovirus Reservoirs
Peterson, A. T., Carroll, D. S., Mills, J. N., et al. (2004) · Emerging infectious diseases · doi:10.3201/eid1012.040346 · Cited by 95 · see citing works
Marburg and Ebola Viruses as Aerosol Threats
Leffel, E. K., & Reed, D. S. (2004) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2004.2.186 · Cited by 88 · see citing works
Clinical Case Definitions for Argentine Hemorrhagic Fever
Harrison, L. H., Halsey, N. A., McKee, K. T., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514749 · Cited by 85 · see citing works
Update: Management of Patients With Suspected Viral Hemorrhagic Fever—United States
(1995) · JAMA · doi:10.1001/jama.1995.03530050020009 · Cited by 82 · see citing works
Lassa fever vaccine
Fisher‐Hoch, S. P., & McCormick, J. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.2.189 · Cited by 81 · see citing works
Pediatric Lassa Fever: A Review of 33 Liberian Cases
Monson, M. H., Cole, A. K., Frame, J. D., et al. (1987) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1987.36.408 · Cited by 79 · see citing works
Infection control for viral haemorrhagic fevers in the African health care setting.
Lloyd, E. S., & Perry, H. N. (1998) · Cited by 74 · see citing works
Recognition of Illness Associated With the Intentional Release of a Biologic Agent
(2001) · JAMA · doi:10.1001/jama.286.17.2088 · Cited by 65 · see citing works
Vaccine research efforts for filoviruses
Hart, M. K. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00064-x · Cited by 63 · see citing works
Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro
Günther, S., Asper, M., Röser, C., et al. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.05.001 · Cited by 61 · see citing works
Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World: Told from the inside by the Man Who Ran It
Cohen, E. A., Alibek, K., Handelman, S., et al. (1999) · Foreign Affairs · doi:10.2307/20049476 · Cited by 60 · see citing works
Towards a vaccine against Ebola virus
Geisbert, T., & Jahrling, P. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.6.777 · Cited by 51 · see citing works
Portraits of Viruses: Arenaviruses
Lehmann-Grube, F. (1984) · Intervirology · doi:10.1159/000149543 · Cited by 49 · see citing works
Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
(2001) · PubMed · Cited by 48 · see citing works
Outbreak of Ebola Hemorrhagic Fever--Uganda, August 2000-January 2001
(2001) · JAMA · doi:10.1001/jama.285.8.1010 · Cited by 48 · see citing works
Imported Lassa Fever: New Jersey, 2004
(2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154219.12612.06 · Cited by 39 · see citing works
Use of a portable forced air system to convert existing hospital space into a mass casualty isolation area
Rosenbaum, R. A., Benyo, J. S., O’Connor, R. E., et al. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.03.012 · Cited by 33 · see citing works
The public health response to a case of Lassa fever in London in 2000
Crowcroft, N. S., Meltzer, M., Evans, M., et al. (2003) · Journal of Infection · doi:10.1016/j.jinf.2003.11.009 · Cited by 26 · see citing works
Update: Outbreak of Ebola Viral Hemorrhagic Fever—Zaire, 1995
(1995) · JAMA · doi:10.1001/jama.1995.03520460030029 · Cited by 24 · see citing works
Viral infections in laboratory persnnel.
Banerjee, K., Np, G., & Mk, G. (1979) · PubMed · Cited by 23 · see citing works
Organisation of health care during an outbreak of Marburg haemorrhagic fever in the Democratic Republic of Congo, 1999
Colebunders, R., Sleurs, H., Pirard, P., Borchert, M., Libande, M. L., Mustin, J. P., Tshomba, A. O., Kinuani, L., Olinda, L. A., Tshioko, F., et al. (2003) · Journal of Infection · doi:10.1016/s0163-4453(03)00122-1 · Cited by 22 · see citing works
Update: Outbreak of Ebola Viral Hemorrhagic Fever—Zaire, 1995
(1995) · JAMA · doi:10.1001/jama.1995.03530050019008 · Cited by 22 · see citing works
Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to Junin virus in rodents
Morales, M. A., Calderón, G. E., Riera, L., et al. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(01)00452-9 · Cited by 21 · see citing works
Lassa fever imported to England
Jones, J. P. (2000) · Weekly releases (1997–2007) · doi:10.2807/esw.04.11.01639-en · Cited by 20 · see citing works
Recognition of illness associated with the intentional release of a biologic agent.
(2001) · PubMed · Cited by 15 · see citing works
Ebola Vaccines Tested in Humans, Monkeys
Vastag, B. (2004) · JAMA · doi:10.1001/jama.291.5.549 · Cited by 14 · see citing works
Update: filovirus infection associated with contact with nonhuman primates or their tissues.
(1990) · PubMed · Cited by 14 · see citing works
Management of viral haemorrhagic fevers in Switzerland
Hugonnet, S., Sax, H., & Pittet, D. (2002) · Eurosurveillance · doi:10.2807/esm.07.03.00340-en · Cited by 12 · see citing works
Management of a patient with Lassa fever to prevent transmission
Swaan, C., van den Broek, P. J., Kampert, E., et al. (2003) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.08.002 · Cited by 7 · see citing works
An outbreak of Ebola virus: Lessons for everyday activities in the intensive care unit
Gradon, J. D. (2000) · Critical Care Medicine · doi:10.1097/00003246-200001000-00065 · Cited by 5 · see citing works
An Uncertain Defense
Gibbs, W. W. (2004) · Scientific American · doi:10.1038/scientificamerican1004-20 · Cited by 4 · see citing works
An uncertain defense. How do you test that a human Ebola vaccine works? You don't.
Gibbs, W. W. (2004) · PubMed · Cited by 3 · see citing works
5. Viral Hemorrhagic Fevers
Okeke, I. N. (2017) · Cornell University Press eBooks · doi:10.7591/9780801460906-009 · Cited by 1 · see citing works

Flagged first, then by citations

Research works printed but not linked: 1

[39]World Health Organization Ebola haemorrhagic fever in Zaire, 1976 Bull World Health Organ 56 2 1978 271 293 307456 PMC2395567

Sorted by citations

The Role of Reactive Species on Innate Immunity
Andrés, C., Pérez de la Lastra, J., Juan, C., Plou, F., & Pérez-Lebeña, E. (2022) · Vaccines · doi:10.3390/vaccines10101735 · Cited by 142 · see citing works

Authors: Pigott, D. C.
Affiliations: University of Alabama at Birmingham (US)
Corresponding author: Pigott, David C.
ORCID: Pigott, David C.
Venue: Critical Care Clinics
Publisher: Elsevier BV
Published: 2005-10
Volume: 21
Issue: 4
Pages: 765-783
ISSN: 0749-0704 (ISSN-L)
DOI: 10.1016/j.ccc.2005.06.007
PMC: PMC7119092
OpenAlex: W2035807000
Cited by: 61
References: 81
Citations by year: 2026: 1 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 5 · 2014: 3 · 2012: 4
FWCI: 0.40
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: public-domain
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Critical Care Clinics (publishedVersion, public-domain)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacillus and Francisella bacterial research
Keywords: viral hemorrhagic fever, bioterrorism, emerging infectious diseases, nosocomial infection risk, healthcare workers, diagnostic challenges, risk factors, barrier precautions, imported infections, public health risk
MeSH terms: Arenaviridae Infections, Decontamination, Hemorrhagic Fevers, Viral, Humans, Lassa Fever, Universal Precautions, Hemorrhagic Fever, Ebola, Bioterrorism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hemorrhagic fever viruses

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks